-460.30
(-0.62%)
-123.70
(-0.54%)
-497.09
(-2.64%)
GET IN TOUCH
SEBI presents Samajh Se Investing Simple:
RISK DISCLOSURES ON DERIVATIVES
|
Genomic Valley Biotech Limited to review financial results at October 30 board meeting <p>Genomic Valley Biotech Limited will hold a board meeting on October 30, 2026, to consider and approve the unaudited financial results for the quarter and half year ended September 30, 2026, according to a regulatory filing with the BSE Limited. The company has also closed the trading window for directors, key managerial personnel, promoters, and designated persons from October 1, 2026, until 48 hours after the results are made public on October 30, 2026.</p> |
INDIAN INDICES
73,249.39 -460.30 (-0.62%)
22,687.65 -123.70 (-0.54%)
GLOBAL INDICES
NA
22,919.11 -732.77(-3.10%)

